Hypocretin/orexin suppresses corticotroph responsiveness in vitro

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 281, Issue 4 50-4, 2001, Pages

  Samson, Willis K ^a,b   Taylor, Meghan M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Adrenocorticotropin; Hypocretin; Hypothalamus; Orexin; Pituitary

Indexed keywords

BRAIN RECEPTOR; CALPHOSTIN C; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE; LUTEINIZING HORMONE; OREXIN; OREXIN A; OREXIN B; OREXIN RECEPTOR; PERTUSSIS TOXIN; PROLACTIN; PROTEIN KINASE C INHIBITOR; THYROTROPIN; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOSE RESPONSE; FEMALE; GROWTH HORMONE RELEASE; INHIBITION KINETICS; LATERAL HYPOTHALAMUS; LUTEINIZING HORMONE RELEASE; MALE; NERVE STIMULATION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; SIGNAL TRANSDUCTION; STRESS; SYMPATHETIC FUNCTION; THYROTROPIN RELEASE;

EID: 0034799503     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.281.4.r1140     Document Type: Article

References (37)

1. Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of corticotropin-releasing factor on cyclic AMP production in rat anterior pituitary cells
2. Immunoreactive orexin-A in human plasma
3. Cellular localization of orexin receptors in human pituitary
4. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
5. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats
6. Distribution of orexin/hypocretin in the rat median eminence and pituitary
7. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems
8. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
9. Orexin A activates locus coeruleus cell firing and increases arousal in the rat
10. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations
11. Effects of orexin on the hypothalamic-pituitary-adrenal system
12. The hypocretin/orexin ligand receptor System: Implications for sleep and sleep disorders
13. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
14. Centrally administered orexin/hypocretin activates HPA axis in rats
15. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
16. Evidence that the stimulation by arginine vasopressin of the release of adrenocorticotropin from the ovine anterior pituitary involves the activation of protein kinase C
17. Differential distribution of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting
18. The extended protein kinase C superfamily
19. Effects of orexin A on thyrotropin-releasing hormone and thyrotropin secretion in rats
20. Distribution of orexin neurons in the adult rat brain
21. A mutation in a case of early-onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
22. Neurons containing hypocretin (orexin) project to multiple neuronal systems
23. Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner
24. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats
25. Central administration of orexin A suppresses basal and domperidone-stimulated plasma prolactin
26. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
27. Cardiovascular regulatory actions of the hypocretins in brain
28. Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel
29. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release
30. The hypocretin/orexin story
31. In vitro simulation of prolactin release by vasoactive intestinal peptide
32. Sympathetic and cardiovascular actions of orexins in conscious rats
33. SB-334867-A: The first selective orexin-1 receptor antagonist
34. Distribution and quantification of immunoreactive orexin A in rat tissues
35. Orexins, orexigenic hypothalamic neuropeptides, suppress the pulsatile secretion of luteinizing hormone in ovariectomized female rats
36. Distribution of orexin receptor mRNA in the rat brain
37. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin